DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 06 · Volume 41 · November 2008 DOI: 10.1055/s-002-14172

Review

  • 221
    Glassman, A.:

    Depression and Cardiovascular Disease

    • Original Paper

    Original Paper

  • 226
    Ehrlich, S.; Franke, L.; Schott, R.; Salbach-Andrae, H.; Pfeiffer, E.; Lehmkuhl, U.; Uebelhack, R.:

    Platelet Monoamine Oxidase Activity in Underweight and Weight-Recovered Females with Anorexia Nervosa

  • 232
    Häßler, F.; Glaser, T.; Pap, A. F.; Beneke, M.; Diefenbacher, A.; Reis, O.:

    A Double-blind Placebo-controlled Discontinuation Study of Zuclopenthixol for the Treatment of Aggressive Disruptive Behaviours in Adults with Mental Retardation – Secondary Parameter Analyses

  • 240
    Arbaizar, B.; Gómez-Acebo, I.; Llorca, J.:

    Quality of Reporting Controlled Clinical Trials on Treatment of the Acute Mania Phase of Bipolar Disorder with New Antipsychotic Drugs

  • 242
    Du, Y.; Scheidt-Nave, C.; Knopf, H.:

    Use of Psychotropic Drugs and Alcohol among Non-Institutionalised Elderly Adults in Germany

  • 252
    Adli, M.; Pilhatsch, M.; Bauer, M.; Köberle, U.; Ricken, R.; Janssen, G.; Ulrich, S.; Bschor, T.:

    Safety of High-intensity Treatment with the Irreversible Monoamine Oxidase Inhibitor Tranylcypromine in Patients with Treatment-resistant Depression

    • Letter

  • 258
    Schulz-Du Bois, C.; Schulz-Du Bois, A. C.; Bewig, B.; Gerstner, I.; Aldenhoff, J. B.; Cascorbi, I.; Ufer, M.:

    Major Increase of Quetiapine Steady-State Plasma Concentration Following Co-Administration of Clarithromycin: Confirmation of the Pharmacokinetic Interaction Potential of Quetiapine

  • 259
    Schlotterbeck, P. M.; Vehren, T.; Milenovic, S.; Hiemke, C.; Kircher, T.; Leube, D.:

    No Influence of Dialysis on Mirtazapine – A Case Report